About Us
DIA is committed to the broad dissemination of information among our members, with continuously improved professional practice as the goal. DIA serves our members in a neutral, global environment that operates independent of the influence of any one organization or authority.
DIA operates as a financially independent nonprofit organization that funds itself from meeting and membership fees. The voluntary efforts of DIA members and speakers allow DIA to provide programs and publications to members at a reasonable, competitive cost.
DIA Mission
DIA fosters innovation to improve health and well being worldwide by:
- Providing invaluable forums to exchange vital information and discuss current issues related to health products, technologies, and services;
- Delivering customized learning experiences;
- Building, maintaining, and facilitating trusted relationships with and among individuals and organizations that drive and share DIA values and mandates; and
- Offering a multidisciplinary neutral environment, respected globally for integrity and relevancy.
DIA Vision
DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well being worldwide.
Links:
DIA Core Values
DIA History
DIA Bylaws
DIA
800 Enterprise Road, Suite 200
Horsham, PA 19044-3595
UNITED STATES
Phone: 215.442.6100
Fax: 215.442.6199
- Ensuring Quality And Balancing Risks For Multiregional Clinical Trials
- 9th Annual DIA Electronic Submissions Conference
- Tomorrow’s Project Manager: Evolving Competencies For Biopharmaceutical Professionals
- Future Direction For Orphan Drugs In Europe
- 2nd Health Technology Assessment (HTA) Conference
- Understanding The Statistical Thinking In Clinical Research For Drug Development
- Sustaining Clinical Trial Disclosure
- DIA’s 8th Annual Canadian Meeting: Fostering Innovation And Access To Drugs
- Conference On Drug & Device Combination Products – Finding The Right Regulatory Strategy
- 7th Latin American Congress Of Clinical Research: Harmonization And The Future Of Drug Development In Latin America
- 2nd Joint DIA/EMA/CMD(h) Variations Conference
- European Medicines Agency - ENCePP Information Day
- 2nd Joint DIA/ European Medicines Agency Innovation Forum: Is The EU Regulatory Framework Ready?
- 11th Conference On European Electronic Document Management
- US And International Prescription Drug Labeling: Comparisons And Important Updates
- Pharmacovigilance And Risk Management 2011
- 14th Annual Workshop In Japan For Clinical Data Management
- 9th Middle East Regulatory Conference - MERC
- CMC Workshop: Translating Science Into Successful Regulatory Submissions
- Electronic Document Management 2011: The Intersection Of Data, Documents And Submissions
- Marketing Pharmaceuticals 2011: Workshop For Regulatory Professionals And Promotional Review Teams
- DIA/FDA Orphan Drug Designation Workshop
- Clinical Data Quality Summit
- DIA/FDA CDER/CBER Computational Science Annual Meeting
- 5th Annual Conference In Japan For Asian New Drug Development
- DIA Hosts Dried Blood Spot Sampling In The Pharmaceutical Industry: Three Years Of Experience And Implementation
- DIA And FDLI Collaborate On First Comprehensive Conference On Biosimilars Since The Enactment Of BPCIA
- Pharmaceutical Industry, Global Regulatory Authorities, And Allied Working Groups Collaborate To Advance Drug Development In Latin America
- DIA Conference Explores Team-Based Approaches To Understanding Drug Development Strategies For Small And Large Molecular Entities
- DIA Launches New Regulatory Affairs Certificate Program

